Perrone Clara, Pomella Silvia, Cassandri Matteo, Pezzella Michele, Giuliani Stefano, Gasperi Tecla, Porrazzo Antonella, Alisi Anna, Pastore Anna, Codenotti Silvia, Fanzani Alessandro, Barillari Giovanni, Conti Libenzio Adrian, De Angelis Biagio, Quintarelli Concetta, Mariottini Paolo, Locatelli Franco, Marampon Francesco, Rota Rossella, Cervelli Manuela
Department of Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Science, "Department of Excellence 2018-2022", University of Rome "Roma Tre", Rome, Italy.
Front Cell Dev Biol. 2023 Jan 23;11:1061570. doi: 10.3389/fcell.2023.1061570. eCollection 2023.
Rhabdomyosarcoma (RMS) is a pediatric myogenic soft tissue sarcoma that includes fusion-positive (FP) and fusion-negative (FN) molecular subtypes. FP-RMS expresses PAX3-FOXO1 fusion protein and often shows dismal prognosis. FN-RMS shows cytogenetic abnormalities and frequently harbors RAS pathway mutations. Despite the multimodal heavy chemo and radiation therapeutic regimens, high risk metastatic/recurrent FN-RMS shows a 5-year survival less than 30% due to poor sensitivity to chemo-radiotherapy. Therefore, the identification of novel targets is needed. Polyamines (PAs) such as putrescine (PUT), spermidine (SPD) and spermine (SPM) are low-molecular-mass highly charged molecules whose intracellular levels are strictly modulated by specific enzymes. Among the latter, spermine oxidase (SMOX) regulates polyamine catabolism oxidizing SPM to SPD, which impacts cellular processes such as apoptosis and DNA damage response. Here we report that low SMOX levels are associated with a worse outcome in FN-RMS, but not in FP-RMS, patients. Consistently, SMOX expression is downregulated in FN-RMS cell lines as compared to normal myoblasts. Moreover, SMOX transcript levels are reduced FN-RMS cells differentiation, being indirectly downregulated by the muscle transcription factor MYOD. Noteworthy, forced expression of SMOX in two cell lines derived from high-risk FN-RMS: 1) reduces SPM and upregulates SPD levels; 2) induces G0/G1 cell cycle arrest followed by apoptosis; 3) impairs anchorage-independent and tumor spheroids growth; 4) inhibits cell migration; 5) increases γH2AX levels and foci formation indicative of DNA damage. In addition, forced expression of SMOX and irradiation synergize at activating ATM and DNA-PKCs, and at inducing γH2AX expression and foci formation, which suggests an enhancement in DNA damage response. Irradiated SMOX-overexpressing FN-RMS cells also show significant decrease in both colony formation capacity and spheroids growth with respect to single approaches. Thus, our results unveil a role for SMOX as inhibitor of tumorigenicity of FN-RMS cells . In conclusion, our results suggest that SMOX induction could be a potential combinatorial approach to sensitize FN-RMS to ionizing radiation and deserve further in-depth studies.
横纹肌肉瘤(RMS)是一种小儿肌源性软组织肉瘤,包括融合阳性(FP)和融合阴性(FN)分子亚型。FP-RMS表达PAX3-FOXO1融合蛋白,预后通常较差。FN-RMS表现出细胞遗传学异常,且经常存在RAS通路突变。尽管采用了多模式的强化化疗和放疗方案,但由于对放化疗敏感性差,高危转移性/复发性FN-RMS的5年生存率低于30%。因此,需要鉴定新的靶点。多胺(PAs),如腐胺(PUT)、亚精胺(SPD)和精胺(SPM),是低分子量的高电荷分子,其细胞内水平受到特定酶的严格调控。其中,精胺氧化酶(SMOX)通过将SPM氧化为SPD来调节多胺分解代谢,这会影响细胞凋亡和DNA损伤反应等细胞过程。在此,我们报告低SMOX水平与FN-RMS患者(而非FP-RMS患者)的较差预后相关。一致地,与正常成肌细胞相比,FN-RMS细胞系中SMOX表达下调。此外,在FN-RMS细胞分化过程中,SMOX转录水平降低,这是由肌肉转录因子MYOD间接下调所致。值得注意的是,在源自高危FN-RMS的两种细胞系中强制表达SMOX:1)降低SPM水平并上调SPD水平;2)诱导G0/G1细胞周期停滞,随后发生凋亡;3)损害非锚定依赖性生长和肿瘤球体生长;4)抑制细胞迁移;5)增加γH2AX水平和病灶形成,表明存在DNA损伤。此外,SMOX的强制表达与辐射协同作用,激活ATM和DNA-PKCs,并诱导γH2AX表达和病灶形成,这表明DNA损伤反应增强。与单一方法相比,经辐射处理的过表达SMOX的FN-RMS细胞在集落形成能力和球体生长方面也显著降低。因此,我们的结果揭示了SMOX作为FN-RMS细胞致瘤性抑制剂的作用。总之,我们的结果表明,诱导SMOX可能是使FN-RMS对电离辐射敏感的一种潜在联合方法,值得进一步深入研究。